Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for OrthoPediatrics Corp. (KIDS : NSDQ)

• Company Description    OrthoPediatrics Corp. is a medical device company. It markets surgical systems for trauma and deformity, bone fractures and reconstruction procedures. OrthoPediatrics Corp. is based in NEW YORK. Number of Employees: 602

• Price / Volume Information    Yesterday's Closing Price: $22.22 Daily Weekly Monthly 20 Day Moving Average: 215,570 shares Shares Outstanding: 26.11 (millions) Market Capitalization: $580.16 (millions) Beta: 0.99 52 Week High: $26.74 52 Week Low: $14.42 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -8.33% -7.68% 12 Week 19.91% 17.38% Year To Date 25.11% 11.61%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2850 Frontier Drive - Warsaw,IN 46582 USA ph: 574-268-6379 fax: 574-269-3692 philip@gilmartinir.com http://www.orthopediatrics.com

• General Corporate Information    Officers David R. Bailey - President and Chief Executive Officer Fred L. Hite - Chief Financial Officer and Chief Operating Office Mark C. Throdahl - Director Bryan W. Hughes - Director Kelly Fische - Director Peer Information OrthoPediatrics Corp. (ABMD) OrthoPediatrics Corp. (DMDS) OrthoPediatrics Corp. (CPWY.) OrthoPediatrics Corp. (EQUR) OrthoPediatrics Corp. (ECIA) OrthoPediatrics Corp. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 68752L100 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 10/27/26 Share - Related Items Shares Outstanding: 26.11 Most Recent Split Date: (:1) Beta: 0.99 Market Capitalization: $580.16 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.25 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.14 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 10/27/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.66 Price/Cash Flow: 133.62 Price / Sales: 2.30 EPS Growth vs. Year Ago Period: -136.36% vs. Previous Quarter: 38.10% Sales Growth vs. Year Ago Period: 15.43% vs. Previous Quarter: 18.78% ROE 06/30/26 - -8.10 03/31/26 - -7.01 12/31/25 - -6.70 ROA 06/30/26 - -5.54 03/31/26 - -4.86 12/31/25 - -4.74 Current Ratio 06/30/26 - 4.78 03/31/26 - 5.21 12/31/25 - 5.55 Quick Ratio 06/30/26 - 2.17 03/31/26 - 2.37 12/31/25 - 2.65 Operating Margin 06/30/26 - -11.05 03/31/26 - -10.02 12/31/25 - -9.91 Net Margin 06/30/26 - -15.72 03/31/26 - -16.31 12/31/25 - -16.77 Pre-Tax Margin 06/30/26 - -15.61 03/31/26 - -16.27 12/31/25 - -16.58 Book Value 06/30/26 - 13.38 03/31/26 - 13.19 12/31/25 - 13.82 Inventory Turnover 06/30/26 - 0.50 03/31/26 - 0.50 12/31/25 - 0.50 Debt-to-Equity 06/30/26 - 0.28 03/31/26 - 0.29 12/31/25 - 0.28 Debt-to-Capital 06/30/26 - 22.09 03/31/26 - 22.30 12/31/25 - 21.86

Powered by Zacks Investment Research ©